Skip to content

GeneDx Holdings

US · WGS #2702 by market cap Listed 1970
45.46 -3.78 -7.68%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $63
    Market Newswire · 2026/6/23
  • GUIDANCE: (WGS) GeneDx Holdings Corp. Expects Q4 Revenue $135.0M
    MT Newswires · 2026/11/10
  • Rating change
    Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $85
    Market Newswire · 2026/5/5
  • Rating change
    Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/7/30
  • Rating change
    Jefferies Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
    Market Newswire · 2026/5/27
  • Rating change
    Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $83
    Market Newswire · 2026/11/10
  • Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $66
    Market Newswire · 2026/11/13
  • Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95
    Market Newswire · 2026/11/10
  • Rating change
    A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $75 to $103
    Market Newswire · 2026/8/5
  • Rating change
    TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $85
    Market Newswire · 2026/7/16
  • Rating change
    A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $70 to $130
    Market Newswire · 2026/5/5
  • Company notice
    GeneDx Holdings: GeneDx Holdings Corporation - Reverse Split Option Symbol: WGS New Symbol: WGS1
    OCC · 2023/5/3
  • Rating change
    BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $90
    Market Newswire · 2026/7/23
  • Rating change
    Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating
    Market Newswire · 2026/6/10
  • Rating change
    Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $85
    Market Newswire · 2026/5/14
  • CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $90
    Market Newswire · 2026/11/10
  • BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $85
    Market Newswire · 2026/11/10
  • Rating change
    Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $74
    Market Newswire · 2026/6/29
  • Rating change
    Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $83
    Market Newswire · 2026/10/1
  • Rating change
    Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $103
    Market Newswire · 2026/9/23
  • Rating change
    Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $130
    Market Newswire · 2026/4/21
  • Rating change
    Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $155
    Market Newswire · 2026/2/25
  • Rating change
    Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $153
    Market Newswire · 2026/3/12
  • Rating change
    Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
    Market Newswire · 2026/3/30
  • Rating change
    CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
    Market Newswire · 2026/4/20

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

GeneDx Holdings discussion 0 comments

Add a comment